FDA Approved Therapy for SOD1 Associated ALS

episode

Neurology® Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Press Pass | Lawrence on Prep for Patriots' Run Defense, Responding & Building Trust 11 min · 23 Sep 2026 · The Jacksonville Jaguars Official Podcast Network

Iran Enters the War of Words; The AI Agenda for the Trump-Xi Summit 26 min · 23 Sep 2026 · Here's the Scoop

Trump vs. the media 21 min · 23 Sep 2026 · The NPR Politics Podcast

Trump meets Xi: what's at stake? 19 min · 23 Sep 2026 · Business Daily

Musings About the Agentic Future 22 min · 23 Sep 2026 · Motley Fool Hidden Gems Investing

China Took Possession of Diverted F-35 Stealth Fighter Parts 2 min · 23 Sep 2026 · Bloomberg News Now

Report any issue

Source

Recorded18 May 2023

Publisherneurology.libsyn.com ↗

Handlerec:5447581

Show notes

Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene. Read the related article on the FDA website. Disclosures can be found at Neurology.org

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related